Age distribution of COVID-19: a key in developing prophylactic medicine for serious lower respiratory tract involvement of coronavirus infection

Abstract

This short editorial suggests that the ACE2 receptor could be the focus of prophylactic and curative medicine for pulmonary involvement of coronavirus infection. The editorial also proposes hypotheses to examine by clinical researchers. [ABSTRACT FROM AUTHOR] Copyright of Electronic Physician is the property of Electronic Physician and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)